{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:22:38Z","timestamp":1787761358753,"version":"build-2784847793"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T00:00:00Z","timestamp":1701216000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Background and Objective:<\/jats:bold> Multimodal management of spinal stenosis is on the rise, and central sensitisation inhibitors are playing an essential role in the treatment of central sensitisation processes. Pregabalin and gabapentin are antiepileptic drugs that decrease presynaptic excitability. The aim of this study was to investigate whether the use of pregabalin and gabapentin is effective in the symptomatic management of spinal stenosis, compared to other drugs, by using pain and disability rating scales. We also assessed the safety profile associated with these drugs.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> We conducted a bibliographic search in the Pubmed, Web of Science, and Cochrane Collaboration Library databases. The inclusion criteria were studies that compared pregabalin or gabapentin to a control group in patients with lumbar spinal stenosis. We included randomized clinical trialsand a comparative retrospective cohort study. The primary clinical endpoints were VAS\/NRS and ODI, measured at two, four, 8\u00a0weeks, and 3\u00a0months, while adverse events and walking distance were also collected. We combined the data using Review Manager 5.4 software.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Our meta-analysis included six studies with a total of 392 patients, with a mean age of 60.3\u00a0years. We observed no significant differences in VAS scores at two, four, and 8\u00a0weeks: MD: 0.23, 95% CI: 0.63 to 1.09; MD: \u22120.04, 95% CI: \u22120.64 to \u22120.57; and MD: \u22120.6, 95% CI: \u22121.22 to 0.02, respectively. However, at 3\u00a0months, we found significant differences in favor of pregabalin with respect to VAS: MD: \u22122.97, 95% CI: \u22123.43 to \u22122.51. We did not observe significant differences respect to the ODI: MD: \u22123.47, 95% CI: \u22127.15 to \u22120.21. Adverse events were significantly higher in the pregabalin\/gabapentin group (OR 5.88, 95% CI: 1.28\u201327.05).<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Our meta-analysis suggests that abapentinoids may have a significant effect on VAS score at 3\u00a0months, but no significant differences were observed in ODI scores, and adverse events were higher in the gabapentinoids group.<\/jats:p>","DOI":"10.3389\/fphar.2023.1249478","type":"journal-article","created":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T04:39:23Z","timestamp":1701232763000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Efficacy and safety of pregabalin and gabapentin in spinal stenosis: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"14","author":[{"given":"Telmo","family":"Mart\u00ednez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"Mariscal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Enrique","family":"de la Rubia Ort\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Barrios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,11,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"137","DOI":"10.12688\/f1000research.16082.1","article-title":"Current concepts and recent advances in understanding and managing lumbar spine stenosis","volume":"8","author":"Bagley","year":"2019","journal-title":"F1000Res"},{"key":"B2","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1093\/pm\/pnz161","article-title":"A review of lumbar spinal stenosis with intermittent neurogenic claudication: disease and diagnosis","volume":"20","author":"Deer","year":"2019","journal-title":"Pain Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"CD007076","DOI":"10.1002\/14651858.CD007076.pub3","article-title":"Pregabalin for neuropathic pain in adults","volume":"1","author":"Derry","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"B4","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.spinee.2010.05.006","article-title":"Treatment of lumbar spinal stenosis: a balancing act","volume":"10","author":"Deyo","year":"2010","journal-title":"Spine J."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1001\/jama.2010.338","article-title":"Trends, major medical complications, and charges associated with surgery for lumbar spinal stenosis in older adults","volume":"303","author":"Deyo","year":"2010","journal-title":"JAMA"},{"key":"B6","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.berh.2009.11.001","article-title":"Lumbar spinal stenosis","volume":"24","author":"Genevay","year":"2010","journal-title":"Best. Pract. Res. Clin. Rheumatol."},{"key":"B7","first-page":"169","article-title":"Pregabalina en el tratamiento del dolor neurop\u00e1tico periferico","volume":"12","author":"Gonzalez-Escalada","year":"2005","journal-title":"Rev. Soc. Esp. Dolor."},{"key":"B8","doi-asserted-by":"publisher","first-page":"133","DOI":"10.4137\/CMAMD.S39938","article-title":"Effects of nasal calcitonin vs. Oral gabapentin on pain and symptoms of lumbar spinal stenosis: a clinical trial study","volume":"9","author":"Haddadi","year":"2016","journal-title":"Clin. Med. Insights Arthritis Musculoskelet. Disord."},{"key":"B9","doi-asserted-by":"publisher","first-page":"221","DOI":"10.2165\/11585030-000000000-00000","article-title":"Intensive monitoring of pregabalin: results from an observational, web-based, prospective cohort study in The Netherlands using patients as a source of information","volume":"34","author":"H\u00e4rmark","year":"2011","journal-title":"Drug Saf."},{"key":"B10","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.joca.2013.02.656","article-title":"Associations between radiographic lumbar spinal stenosis and clinical symptoms in the general population: the Wakayama Spine Study","volume":"21","author":"Ishimoto","year":"2013","journal-title":"Osteoarthr. Cartil."},{"key":"B11","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.spinee.2016.02.049","article-title":"Comparative study of the efficacy of limaprost and pregabalin as single agents and in combination for the treatment of lumbar spinal stenosis: a prospective, double-blind, randomized controlled non-inferiority trial","volume":"16","author":"Kim","year":"2016","journal-title":"Spine J."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1007\/s00586-020-06339-1","article-title":"Prevalence of lumbar spinal stenosis in general and clinical populations: a systematic review and meta-analysis","volume":"29","author":"Kruger Jensen","year":"2020","journal-title":"Eur. Spine J."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"h6234","DOI":"10.1136\/bmj.h6234","article-title":"Management of lumbar spinal stenosis","volume":"352","author":"Lurie","year":"2016","journal-title":"BMJ"},{"key":"B15","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1212\/WNL.0000000000001168","article-title":"Double-blind, randomized, controlled, crossover trial of pregabalin for neurogenic claudication","volume":"84","author":"Markman","year":"2015","journal-title":"Neurology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"m1315","DOI":"10.1136\/bmj.m1315","article-title":"Pregabalin and gabapentin for pain","volume":"28","author":"Mathieson","year":"2020","journal-title":"BMJ"},{"key":"B17","doi-asserted-by":"publisher","first-page":"73","DOI":"10.5387\/fms.2018-07","article-title":"Comparisons between the efficacy of limaprost alfadex and pregabalin in cervical spondylotic radiculopathy: design of a randomized controlled trial","volume":"64","author":"Onda","year":"2018","journal-title":"Fukushima J. Med. Sci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"590652","DOI":"10.1155\/2013\/590652","article-title":"Lumbar spinal stenosis has a negative impact on quality of life compared with other comorbidities: an epidemiological cross-sectional study of 1862 community-dwelling individuals","volume":"2013","author":"Otani","year":"2013","journal-title":"Sci. World J."},{"key":"B19","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.spinee.2007.05.003","article-title":"Assessment of health-related quality of life after surgical treatment of focal symptomatic spinal stenosis compared with osteoarthritis of the hip or knee","volume":"8","author":"Rampersaud","year":"2008","journal-title":"Spine J."},{"key":"B20","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/s0030-5898(02)00069-x","article-title":"Lumbar spinal stenosis. Treatment strategies and indications for surgery","volume":"1","author":"Sengupta","year":"2003","journal-title":"Orthop. Clin. North Am."},{"key":"B21","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1097\/BSD.0b013e3181de4b61","article-title":"Long-term follow-up of revision decompressive lumbar spinal surgery in elderly patients","volume":"1","author":"Shabat","year":"2011","journal-title":"J. Spinal Disord. Tech."},{"key":"B22","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1046\/j.1445-2197.2003.02748.x","article-title":"Methodological index for non-randomized studies (minors): development and validation of a new instrument","volume":"73","author":"Slim","year":"2003","journal-title":"ANZ J. Surg."},{"key":"B23","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s00776-014-0642-z","article-title":"One-year follow-up for the therapeutic efficacy of pregabalin in patients with leg symptoms caused by lumbar spinal stenosis","volume":"19","author":"Takahashi","year":"2014","journal-title":"J. Orthop. Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1097\/BRS.0b013e3181e0f04d","article-title":"Surgical versus nonoperative treatment for lumbar spinal stenosis four-year results of the Spine Patient Outcomes Research Trial","volume":"35","author":"Weinstein","year":"2010","journal-title":"Spine"},{"key":"B25","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1097\/01.brs.0000261029.29170.e6","article-title":"The efficiency of gabapentin therapy in patients with lumbar spinal stenosis","volume":"32","author":"Yaksi","year":"2007","journal-title":"Spine"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1249478\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T04:39:25Z","timestamp":1701232765000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1249478\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,29]]},"references-count":25,"alternative-id":["10.3389\/fphar.2023.1249478"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2023.1249478","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,29]]},"article-number":"1249478"}}